Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2023/10/059333
CTRI/2023/10/059333Not yet recruitingUnknown

Evaluation of Neutrophil to Lymphocyte (NLR),Platelet to lymphocyte (PLR) and Lymphocyte to Monocyte (LMR) ratios in peripheral blood of patients having periodontitis with type 2 diabetes mellitus before and one month after scaling and root planing - NI

Dr. Nikita Vikasrao Palkar0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1.Subjects with clinically healthy periodontium, with no attachment loss and probing depth of less than or equal to 3 mm, <10%bleeding sites, subject with gingival index score of maximum up to <1, included which were considered to be relatively healthy and subject having HbA1c level between 4%–6% considered as control group.
  • •2.Group B:
  • •1.Patients with Periodontitis stage II and stage III as per the 2017 American Academy of Periodontology Classification.
  • •2.Patients with periodontitis stage II having clinical attachment loss of 3-4mm and maximum probing pocket depth =5 mm.
  • •3.Patients with periodontitis stage III having clinical attachment loss of =5 mm and maximum probing pocket depth = 6mm.35
  • •3.Group C:
  • •1.Patients with periodontitis (stage II and stage III as per the 2017 American Academy of Periodontology classification) with diagnosed case of type 2 diabetes mellitus (Good diabetes control, HbA1c level 7%)

Exclusion Criteria

  • •1.Patient refusal
  • •2.Patient who has received periodontal treatment in last 6months.
  • •3.Patient who is smoker or consuming any other form of tobacco.
  • •4.Pregnant, lactating or postmenopausal women.
  • •5.Hospitalized patients.
  • •6.Subjects consuming antibiotic or other drugs in the past 6 months that affect their periodontal status.
  • •7.History of any systemic disease which influences the values of NLR, PLR, and LMR ratio like any malignancy, cardiovascular diseases, rheumatic diseases, bipolar disorder, thyrotoxicosis, psoriasis other than type 2 diabetes mellitus for the test group (Group III)
  • •8.History of any systemic disease for the control group.
  • •9.If subject cannot maintain oral hygiene after non-surgical periodontal therapy (Gingival index score >1, plaque index >1).

Investigators

Sponsor
Dr. Nikita Vikasrao Palkar

Similar Trials

Not yet recruiting
Unknown
eutrophil Lymphocyte Ratio (NLR) for Prediction of Mortality in Sepsis patient
CTRI/2024/01/061385school of medical sciences and research sharda university
Not yet recruiting
Phase 2
Comparison of ratio of blood components in pyorrhea patients before and after treatment.
CTRI/2024/03/064169DR SURABHI TANDE
Not yet recruiting
Unknown
Significance of blood cell counts ratio that is NLR (Neutrophil-to-Lymphocyte Ratio) and PLR (Platelet-to-Lymphocyte Ratio) in predicting Post-operative readmissions, ICU stay and reinterventions and correlate to stage of the disease in final reports in cases of Gastro-intestinal cancers.
CTRI/2023/08/056403Dr. Atishay Agarwal
Not yet recruiting
Unknown
Importance of white cell, platelet cell ratio in long standing obstructive lung disease
CTRI/2024/03/063588Dr Satya Roy
Not yet recruiting
Not Applicable
Predicting the time of delivery in women who are prone for preterm labor by simple blood test-White cell and Platelet counts.
CTRI/2021/04/032474Kasturba Medical College Manipal